Magenta Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Magenta Therapeutics, Inc.‘s stocks are currently a part of 80 hedge funds’ portfolios, which represents 80.98% of the total amount of its stocks outstanding. This makes up a total of 44.49M shares of Magenta Therapeutics, Inc.. Compared to the previous quarter, the number grew by 0.29% or 128.71K shares more. As for the holding position changes, 23.75% (19) of current hedge fund investors increased the number of shares held, 33.75% (27) of current holders sold a part of the shares held, and 25% (20) closed the holdings completely. 12 hedge funds are new holders of Magenta Therapeutics, Inc. stock in Q1 2022, it is 15% of total holders.
Hedge funds holding Magenta Therapeutics (Q2 2018 – Q1 2022)
| Q2 2018 | 48 |
|---|---|
| Q3 2018 | 49 |
| Q4 2018 | 52 |
| Q1 2019 | 62 |
| Q2 2019 | 66 |
| Q3 2019 | 70 |
| Q4 2019 | 71 |
| Q1 2020 | 69 |
| Q2 2020 | 93 |
| Q3 2020 | 91 |
| Q4 2020 | 88 |
| Q1 2021 | 87 |
| Q2 2021 | 93 |
| Q3 2021 | 89 |
| Q4 2021 | 87 |
| Q1 2022 | 80 |
Hedge funds changes in Magenta Therapeutics positions (Q2 2018 – Q1 2022)
| Q2 2018 | 48 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q3 2018 | 18 | 13 | 5 | 17 | -4 |
| Q4 2018 | 14 | 14 | 16 | 10 | -2 |
| Q1 2019 | 16 | 24 | 7 | 6 | 9 |
| Q2 2019 | 14 | 25 | 10 | 8 | 9 |
| Q3 2019 | 9 | 24 | 18 | 5 | 14 |
| Q4 2019 | 16 | 19 | 18 | 10 | 8 |
| Q1 2020 | 9 | 25 | 18 | 11 | 6 |
| Q2 2020 | 27 | 31 | 22 | 3 | 10 |
| Q3 2020 | 16 | 35 | 15 | 18 | 7 |
| Q4 2020 | 7 | 35 | 24 | 9 | 13 |
| Q1 2021 | 13 | 25 | 29 | 14 | 6 |
| Q2 2021 | 16 | 38 | 22 | 10 | 7 |
| Q3 2021 | 15 | 31 | 23 | 19 | 1 |
| Q4 2021 | 17 | 25 | 20 | 20 | 5 |
| Q1 2022 | 12 | 19 | 27 | 20 | 2 |
Hedge funds changes in Magenta Therapeutics stock options (Q2 2018 – Q1 2022)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 3,000 | 2,000 |
| Q1 2020 | 1,000 | 1,000 |
| Q2 2020 | 4,000 | 117,000 |
| Q3 2020 | 3,000 | 89,000 |
| Q4 2020 | 46,000 | 164,000 |
| Q1 2021 | 739,000 | 182,000 |
| Q2 2021 | 1,000 | 0 |
| Q3 2021 | 86,000 | 0 |
| Q4 2021 | 3,000 | 52,000 |
| Q1 2022 | 1,000 | 2,000 |